2-Phenylpyrimidine-5-carbonitrile

Catalog No.: 
ACUKLJ382
CAS No.: 
85386-15-8
Molecular Formula: 
C11H7N3
Molecular Weight: 
181.20
2-Phenylpyrimidine-5-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$85.00InquiryInquiry
250mg97%$161.00InquiryInquiry
1g97%$309.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Phenylpyrimidine-5-carbonitrile
IUPAC Name2-phenylpyrimidine-5-carbonitrile
MDL No.MFCD06797256
Molecular FormulaC11H7N3
Molecular Weight181.20
SMILESN#CC1=CN=C(C2=CC=CC=C2)N=C1
InChI KeyOZDRGIMFRMFITG-UHFFFAOYSA-N
Synonym2-PHENYL-PYRIMIDINE-5-CARBONITRILE;5-Pyrimidinecarbonitrile, 2-phenyl-;2-Phenyl-5-pyrimidinecarbonitrile
CAS No.85386-15-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACUKLJ382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGOVS347 route compound structure diagram
    ACGOVS3471753-50-0In Stock
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6In Stock
  4. Then
  5. ACUKLJ382 route product structure diagram
    ACUKLJ38285386-15-8
Inquiry

2. ACUKLJ382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIUGZ623 route compound structure diagram
    ACIUGZ62338696-20-7In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACUKLJ382 route product structure diagram
    ACUKLJ38285386-15-8
Inquiry

3. ACUKLJ382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUKLJ382 route product structure diagram
    ACUKLJ38285386-15-8
Inquiry

Comments (0)